The AMA Code of Medical Ethics offers guidance on decision making for unrepresented patients in Opinion 5.2, "Advance Directives." This opinion discusses situations in which a surrogate is needed because the patient is unable to make his or her own health care decisions, but none is available.
Generally, patients are free to exercise autonomy in making decisions about their health care. However, as I have written elsewhere, "not all patients have capacity (a clinical standard applying to a particular decision at a particular point in time) or competence (a legal standard applying to all decisions at all times)" to make these choices. 1 The American Medical Association (AMA) Code of Medical Ethics' Opinion 2.1.2, "Decisions for Adult Patients Who Lack Capacity," notes that "When a patient lacks decision-making capacity, the physician has an ethical responsibility to … identify an appropriate surrogate to make decisions on the patient's behalf." Ideally, this person is designated by a patient "as surrogate through a durable power of attorney for health care or other mechanism." a patient about whom little, if anything, is known is amplified in end-of-life care decisions. Opinion 2.1.2 states that decisions should be made "in keeping with the best interest standard when the patient's preferences and values are not known and cannot reasonably be inferred." 2 The opinion specifies that the following should be taken into account in best interest decisions:
1. The pain and suffering associated with the intervention 2. The degree of and potential for benefit 3. Impairments that may result from the intervention 4. Quality of life as experienced by the patient 2 It can be difficult for a guardian, when one can be secured, or a care team to ascertain what is in a patient's best interest, particularly since patients who lack decision-making capacity and representation are vulnerable due, in part, to their anonymity and aloneness. The AMA Code reminds us that ethics committees or other institutional resources can be helpful in difficult cases, such as those involving unrepresented patients.
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